MedPath

To study the effect of a drug named Dexmedetomidine which is administered through nose before insertion of tube through windpipe for management of anaesthesia

Phase 3
Conditions
Health Condition 1: J984- Other disorders of lung
Registration Number
CTRI/2024/02/063320
Lead Sponsor
Roys Prathima G
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients undergoing elective lung surgery including pulmonary lobectomy, pneumonectomy, metastasectomy, decortication, etc who require Left sided DLT placement

ASA Physical status I to III

Exclusion Criteria

1. Patients with difficult airway

2. Surgeries requiring Right sided Double Lumen Tube insertion

3. Uncontrolled hypertensives

4. Heart disease with ejection fraction less than 40%

5. Body mass index more than 35 kg/ m2

6. History suggestive of sensitivity to drugs used during the study

7. Patients with bradycardia (heart rate < 50 beats per minute) or any heart block

8. Nasal pathology

9. History of reactive airway disease

10. Hepatic or Renal impairment

11. Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath